Giiant Pharma Inc.
PrivateLast Round
Grant
Jan 10, 2023
Total Funding Raised
$12.51M
Company Overview
Giiant Pharma Inc. operates in Healthcare & Life Sciences and is based in Montreal, Quebec. Its latest recorded funding round was a Grant round in January 2023.
Giiant Pharma Inc. is a biotechnology company that develops gut-restricted, small molecule therapeutics for inflammatory bowel diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Giiant Pharma Inc. Comparables
Compare Giiant Pharma Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Oncostellae | 87% | |
| Palisade Bio | 83% | |
| PIPr Therapeutics | 81% |
For institutional investors. Book with your work email.
Giiant Pharma Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 10, 2023 | ||||
| Seed | Jun 30, 2021 | ||||
| Seed | May 21, 2021 |
For institutional investors. Book with your work email.
Giiant Pharma Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Amplitude Ventures | Seed |
| Fonds de solidarité FTQ | Seed |
| Consortium Québécois sur la découverte du médicament | Seed |
| AQC Capital | Seed |
| Genesys Capital | Seed |
| Anges Quebec | Seed |
| Theodorus | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 30, 2021
$1M round led by AQC Capital and Consortium Québécois sur la découverte du médicament.
For institutional investors. Book with your work email.
Giiant Pharma Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Giiant Pharma Inc.'s valuation, stock price, and market status.
Is Giiant Pharma Inc. a public or private company?
Giiant Pharma Inc. is a private company.
What is the current stock price of Giiant Pharma Inc.?
Giiant Pharma Inc. is a private company, so its shares have no public market price. Caplight tracks Giiant Pharma Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Giiant Pharma Inc. worth (valuation)?
Valuation information for Giiant Pharma Inc. is not publicly available.
Can I buy Giiant Pharma Inc. stock?
Giiant Pharma Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Giiant Pharma Inc.'s last funding round?
Giiant Pharma Inc.'s most recent funding round was Grant on January 10, 2023.
Who are the main investors in Giiant Pharma Inc.?
Key investors in Giiant Pharma Inc. include Amplitude Ventures, Consortium Québécois sur la découverte du médicament, AQC Capital, Genesys Capital.
Will Giiant Pharma Inc. IPO soon?
No public IPO plans have been announced for Giiant Pharma Inc..
How can I track Giiant Pharma Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Giiant Pharma Inc.'s shares on secondary markets.